Neuropeptides
Volume 43, Issue 6 , Pages 457-463, December 2009

NPY regulation of bone remodelling

  • Nicola J. Lee

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, St. Vincent’s Hospital, 384 Victoria St, Darlinghurst, Sydney, NSW 2010, Australia
    • ,
  • Herbert Herzog

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, St. Vincent’s Hospital, 384 Victoria St, Darlinghurst, Sydney, NSW 2010, Australia
    • Faculty of Medicine, University of NSW, Sydney, NSW, Australia
    • Corresponding Author InformationCorresponding author. Address: Neuroscience Research Program, Garvan Institute of Medical Research, St. Vincent’s Hospital, 384 Victoria St, Darlinghurst, Sydney, NSW 2010, Australia. Tel.: +61 2 9295 8296; fax: +61 2 9295 8281.

published online 14 September 2009.

Abstract 

Neuropeptide Y (NPY), a classic neuronal regulator of energy homeostasis, is now also known to be involved in the control of bone homeostasis. Of the five known Y receptors through which the NPY family of ligands signals, the Y1 and Y2 receptors have so far been implicated in the control of osteoblast activity and thus bone formation. Analysis of brain specific NPY overexpressing and Y receptor knockout models has revealed a powerful anabolic pathway likely involving hypothalamic Y2 receptors and osteoblastic Y1 receptors. Furthering our understanding of the mechanisms underlying the involvement of the NPY system in the control of bone could lead to the development of therapies to improve bone mass in patients with diseases such as osteoporosis.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(09)00089-4

doi:10.1016/j.npep.2009.08.006

Neuropeptides
Volume 43, Issue 6 , Pages 457-463, December 2009

Article Tools

* Image Usage & Resolution